Sarah Zielsdorf, MD, MS - Beyond Tired: CFS/ME or Not? (2017 Conference) (LDN, low dose naltrexone)

Dr Zielsdorf shares case studies of patients with CFS and ME and goes into the evidence showing that the hallmark of CFS/ME is a mitochondrial dysfunction and intense diet, nutritional antioxidant and other lifestyle modifications are the primary therapy for this disorder. 

John Robinson, NMD - Thyroid Autoimmunity Causal Relationships (2017 Conference) (LDN, low dose naltrexone)

Paul Battle PA-C - Effects of LDN on Cancer (2017 Conference) (LDN, low dose naltrexone)

Kent Holtorf, MD - Immune Dysfunction and Chronic Lyme Disease (2017 Conference) (LDN, low

Dr Kent Holtorf deals specifically with Lyme Disease in this presentation and its impact upon the immune system, explaining the process he uses to test for and diagnose Lyme. 

Phil Boyle, MD - Low Dose Naltrexone in Pregnancy (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Boyle's Pregnancy Presentation

The title of this presentation is “Low Dose Naltrexone in pregnancy: comparison of outcomes between users and non-users during pregnancy”.

Martin Dayton, DO - LDN Case Studies (2016 Conference) (LDN, low dose naltrexone)

Dr Martin Dayton shares three case studies of patients suffering from follicular B-cell non Hodgkin's Lymphoma who were treated with nothing more than Low Dose Naltrexone (LDN). 

Kent Holtorf, MD - Immune Modulatory Treatments for Chronic Illness (2018 Conference) (LDN, low dose naltrexone)

Laurie Marzell, ND - LDN Case Studies (2017 Conference) (LDN, low dose naltrexone)

Jill Cottel, MD - LDN in Primary Care - Case Studies (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Cottel's LDN in Primary Care Presentation

Akbar Khan, MD - LDN for Cancer prevention (2018 Conference) (LDN, low dose naltrexone)